Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclax. | Pharmacol Res Perspect;3(5): e00178, 2015 Oct. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

Secretaria de Estado da Saúde - BVS

Rede de Informação e Conhecimento

Localizar descritor de assunto Busca Avançada

Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclax.

Ackler, Scott; Oleksijew, Anatol; Chen, Jun; Chyla, Brenda J; Clarin, Jerry; Foster, Kelly; McGonigal, Thomas; Mishra, Sasmita; Schlessinger, Sally; Smith, Morey L; Tahir, Stephen K; Leverson, Joel D; Souers, Andrew J; Boghaert, Erwin R; Hickson, Jonathan.

Afiliação

Ackler S; AbbVie Inc. North Chicago, Illinois.
Oleksijew A; AbbVie Inc. North Chicago, Illinois.
Chen J; AbbVie Inc. North Chicago, Illinois.
Chyla BJ; AbbVie Inc. North Chicago, Illinois.
Clarin J; AbbVie Inc. North Chicago, Illinois.
Foster K; AbbVie Inc. North Chicago, Illinois.
McGonigal T; AbbVie Inc. North Chicago, Illinois.
Mishra S; AbbVie Inc. North Chicago, Illinois.
Schlessinger S; AbbVie Inc. North Chicago, Illinois.
Smith ML; AbbVie Inc. North Chicago, Illinois.
Tahir SK; AbbVie Inc. North Chicago, Illinois.
Leverson JD; AbbVie Inc. North Chicago, Illinois.
Souers AJ; AbbVie Inc. North Chicago, Illinois.
Boghaert ER; AbbVie Inc. North Chicago, Illinois.
Hickson J; AbbVie Inc. North Chicago, Illinois.

Pharmacol Res Perspect ; 3(5): e00178, 2015 Oct.

Article em En | MEDLINE | ID: mdl-26516589

Palavras-chave

Apoptosis; Bcl-2 family proteins; bioluminescent imaging; drug therapy; leukemia/lymphoma; systemic engraftment

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article